The People of Tulane Cancer Center Research
Oliver Sartor, M.D.
Dr. Oliver Sartor is the Laborde Professor of Cancer Research, director of the Prostate Cancer Program at Tulane University School of Medicine, and medical director of the Tulane Cancer Center. Dr. Sartor's research and clinical interests have focused broadly on prostate cancer over the past 25 years. His publications range from genetic studies on prostate cancer, to studies of prostate cancer in ethnic populations, to clinical trials involving novel agents. He collaborates widely and has lectured in over 25 countries. Among other duties, he is past chairman of the Integration Panel for the Department of Defense's Congressionally Directed Medical Research Program in Prostate Cancer and he is currently the medical oncology chairman of the GU Oncology Committee at the NRG, a cooperative group funded by the National Cancer Institute. He has led a number of large international phase III trials in prostate cancer, including those leading to the FDA approval of novel agents, such as samarium-153 EDTMP, radium-223 dichoride, and cabazitaxel. He has over 250 peer-reviewed publications in addition to numerous book chapters, abstracts, and other writings.
1430 Tulane Ave, New Orleans, LA 70112 504-988-8070 email@example.com